Appropriate Terminology for Early-Stage Alzheimer Disease
The appropriate term for an older adult with measurable memory and cognitive deficits who can still perform most instrumental activities of daily living independently is "mild cognitive impairment (MCI) due to Alzheimer disease" or "prodromal Alzheimer disease"—these terms are interchangeable. 1, 2
Core Diagnostic Framework
The terminology reflects a critical distinction in the Alzheimer disease continuum. MCI due to AD represents the symptomatic predementia phase of Alzheimer disease, occurring after the preclinical stage but before dementia develops. 1
Defining Characteristics of MCI Due to AD
The diagnosis requires all of the following elements:
Cognitive concern reflecting a change in cognition reported by the patient, informant, or clinician, with historical or observed evidence of decline 1, 2
Objective cognitive impairment in one or more domains (memory, executive function, attention, language, visuospatial skills) that is greater than expected for the patient's age and educational level 1, 2
Preserved independence in functional abilities with minimal or no impairment in instrumental activities of daily living (IADLs)—patients may have slight difficulty with complex tasks like managing finances, following intricate recipes, or shopping, but maintain overall independence 1, 2
No dementia—the cognitive changes are not severe enough to significantly impair social or occupational functioning 1, 2
Clinical Presentation Patterns
Memory-Predominant (Amnestic) Presentation
The most common presentation involves impairment in learning and recall of recently learned information, with deficits in at least one other cognitive domain. 1 This amnestic subtype is most consistently predictive of progression to Alzheimer dementia. 1, 2
Non-Amnestic Presentations
MCI due to AD can also present with predominant deficits in:
- Language (word-finding difficulties) 1
- Visuospatial function (spatial cognition problems) 1
- Executive function (impaired reasoning, judgment, problem-solving) 1
Neuropsychiatric Features
Between 35% and 85% of patients with MCI exhibit at least one neuropsychiatric symptom, most commonly depression, irritability, apathy, anxiety, agitation, and sleep problems. 1, 3 These symptoms serve as additional diagnostic clues and may help predict disease progression. 1
Distinction from Other Stages
Not "Early-Stage Dementia"
This presentation does not meet criteria for dementia because the patient maintains independence in functional abilities and does not have significant impairment in social or occupational functioning. 1, 2 The key differentiator is that IADLs are relatively preserved, though patients may require minimal assistance with the most complex tasks. 1, 2
Not "Preclinical AD"
Preclinical AD (Stage 2 in the Alzheimer's Association framework) refers to individuals with biomarker evidence of AD pathology but either no symptoms or only subjective cognitive decline without objective impairment on testing. 1 The scenario described involves measurable, objective cognitive deficits, which moves beyond the preclinical stage. 1
Prognostic Significance
Between 30% and 50% of patients with MCI convert to AD dementia over 5-10 years, with annualized conversion rates of 8-17% in clinical samples and 5-12% in community samples. 1 When biomarker evidence of AD pathology is present (low CSF Aβ42, elevated tau, positive amyloid PET), the risk of progression to dementia increases to approximately 90% within 5 years. 1
Terminology Evolution and Equivalence
The 2011 NIA-AA criteria established "MCI due to AD" as the preferred term for this stage. 1 The International Working Group uses "prodromal AD" to describe the same clinical entity, requiring episodic memory decline plus positive biomarker evidence. 1 Both terms are considered interchangeable in current practice. 1
Common Pitfall to Avoid
Never dismiss this presentation as "normal aging" or use vague terms like "age-related memory decline." 4 The presence of objective cognitive impairment that exceeds what is expected for age and education, even with preserved functional independence, warrants the specific diagnosis of MCI due to AD when the clinical presentation and biomarkers (if obtained) support an Alzheimer etiology. 1, 2